Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Australia
/
Healthcare
/
Ansell
ANN
Ansell
Acquisitions And New Launches Will Streamline Global Operations
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
17 May 25
Updated
15 Aug 25
19
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
AU$35.09
9.3% undervalued
intrinsic discount
15 Aug
AU$31.83
Loading
1Y
17.4%
7D
1.9%
Author's Valuation
AU$35.1
9.3% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
AU$35.1
9.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$2.3b
Earnings US$228.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.65%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.62%
Calculation
US$228.59m
Earnings '28
x
18.11x
PE Ratio '28
=
US$4.14b
Market Cap '28
US$4.14b
Market Cap '28
/
145.85m
No. shares '28
=
US$28.39
Share Price '28
US$28.39
Share Price '28
Discounted to 2025 @ 7.62% p.a.
=
US$22.77
Fair Value '25
US$22.77
Fair Value '25
Converted to AUD @ 1.5321 USD/AUD Exchange Rate
=
AU$34.89
Fair Value '25